BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35039876)

  • 1. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
    Zhang J; Sun B; Yang J; Chen Z; Li Z; Zhang N; Li H; Shen L
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease.
    Liang Y; Chen C; Xia B; Wu W; Tang J; Chen Q; Tang L; Yang H; Zhang Z; Lu Y; Yang Y; Zhao Y
    Biomed Res Int; 2019; 2019():4379639. PubMed ID: 30834264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice.
    Chang FW; Wang SD; Lu KT; Lee EH
    Brain Res Bull; 1993; 31(3-4):253-66. PubMed ID: 7683960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
    Watanabe Y; Kato H; Araki T
    Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ginsenoside Rg1 modulates COX-2 expression in the substantia nigra of mice with MPTP-induced Parkinson disease through the P38 signaling pathway].
    Wang Q; Zheng H; Zhang ZF; Zhang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1594-8. PubMed ID: 18819875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
    Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease].
    Li WW; Yang R; Cai DF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Mar; 28(3):248-51. PubMed ID: 18476428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
    Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
    Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.
    Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
    Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Ye Q; Yuan X; Zhou J; Yuan C; Yang X
    J Tradit Chin Med; 2017 Apr; 37(2):244-51. PubMed ID: 29960635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
    Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease.
    Liu N; Bai L; Lu Z; Gu R; Zhao D; Yan F; Bai J
    J Neuroinflammation; 2022 Jan; 19(1):26. PubMed ID: 35093118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mouse MPTP model: gene expression changes in dopaminergic neurons.
    Kühn K; Wellen J; Link N; Maskri L; Lübbert H; Stichel CC
    Eur J Neurosci; 2003 Jan; 17(1):1-12. PubMed ID: 12534964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.